CCEL
Price
$4.20Alerts
Change
-$0.43 (-9.29%)
Updated
Nov 18, 04:56 PM (EDT)
Capitalization
39.43M
100 days until earnings call
Intraday BUY SELL Signals
NHC
Price
$201.89Alerts
Change
-$3.88 (-1.89%)
Updated
Nov 18, 04:59 PM (EDT)
Capitalization
3.27B
Intraday BUY SELL Signals
Interact to see
Advertisement

CCEL vs NHC

CCEL vs NHC Comparison Chart in %
View a ticker or compare two or three
VS
CCEL vs. NHC commentary
Nov 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCEL is a StrongBuy and NHC is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CCEL with price predictions
Nov 18, 2026

CCEL in upward trend: price may ascend as a result of having broken its lower Bollinger Band on November 18, 2026

CCEL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 46 of 49 cases where CCEL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 10-day moving average for CCEL crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.

Following a +10.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where CCEL advanced for three days, in 150 of 214 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

The Aroon Indicator entered an Uptrend today. In 79 of 97 cases where CCEL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.

Bearish Trend Analysis

The 10-day RSI Indicator for CCEL moved out of overbought territory on November 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In 24 of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Momentum Indicator moved below the 0 level on November 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CCEL as a result. In 109 of 119 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for CCEL turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 44 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.

CCEL moved below its 50-day moving average on November 18, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CCEL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-2.220) is normal, around the industry mean (204.532). P/E Ratio (-15.774) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (2.680) is also within normal values, averaging (2.498). Dividend Yield (0.123) settles around the average of (0.154) among similar stocks. P/S Ratio (1.141) is also within normal values, averaging (2.688).

The Tickeron SMR rating for this company is 12 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. CCEL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CCEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

A.I.Advisor
a Summary for NHC with price predictions
Nov 17, 2026

NHC sees MACD Histogram just turned negative

NHC saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 26, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 43 instances where the indicator turned negative. In 23 of the 43 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 53%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NHC as a result. In 44 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 46%.

NHC moved below its 50-day moving average on October 26, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NHC crossed bearishly below the 50-day moving average on November 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 47%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NHC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NHC's RSI Oscillator exited the oversold zone, 8 of 16 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 50%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 35 of 56 cases where NHC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 62%.

Following a +1.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where NHC advanced for three days, in 210 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

NHC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 213 of 286 cases where NHC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 6 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 24 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating fairly steady price growth. NHC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.914) is normal, around the industry mean (204.532). P/E Ratio (23.128) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (2.498). Dividend Yield (0.013) settles around the average of (0.154) among similar stocks. P/S Ratio (2.278) is also within normal values, averaging (2.688).

The Tickeron SMR rating for this company is 61 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
CCEL vs NHC: Fundamental Ratings
CCEL
NHC
OUTLOOK RATING
1..100
8218
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
60
Fair valued
PROFIT vs RISK RATING
1..100
1006
SMR RATING
1..100
1261
PRICE GROWTH RATING
1..100
4055
P/E GROWTH RATING
1..100
8824
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CCEL's Valuation (7) in the null industry is somewhat better than the same rating for NHC (60) in the Hospital Or Nursing Management industry. This means that CCEL’s stock grew somewhat faster than NHC’s over the last 12 months.

NHC's Profit vs Risk Rating (6) in the Hospital Or Nursing Management industry is significantly better than the same rating for CCEL (100) in the null industry. This means that NHC’s stock grew significantly faster than CCEL’s over the last 12 months.

CCEL's SMR Rating (12) in the null industry is somewhat better than the same rating for NHC (61) in the Hospital Or Nursing Management industry. This means that CCEL’s stock grew somewhat faster than NHC’s over the last 12 months.

CCEL's Price Growth Rating (40) in the null industry is in the same range as NHC (55) in the Hospital Or Nursing Management industry. This means that CCEL’s stock grew similarly to NHC’s over the last 12 months.

NHC's P/E Growth Rating (24) in the Hospital Or Nursing Management industry is somewhat better than the same rating for CCEL (88) in the null industry. This means that NHC’s stock grew somewhat faster than CCEL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CCELNHC
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
46%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 2 days ago
53%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 2 days ago
47%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
46%
Advances
ODDS (%)
Bullish Trend 7 days ago
70%
Bullish Trend 7 days ago
68%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 2 days ago
51%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 2 days ago
54%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 2 days ago
74%
COMPARISON
Comparison
Nov 19, 2026
Stock price -- (CCEL: $4.63 vs. NHC: $205.77)
Brand notoriety: CCEL and NHC are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: CCEL: 149% vs. NHC: 69%
Market capitalization -- CCEL: $39.43M vs. NHC: $3.27B
CCEL [@Hospital/Nursing Management] is valued at $39.43M. NHC’s [@Hospital/Nursing Management] market capitalization is $3.27B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $20.9K to $107.17B. The average market capitalization across the [@Hospital/Nursing Management] industry is $5.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCEL’s FA Score shows that 2 FA rating(s) are green while NHC’s FA Score has 2 green FA rating(s).

  • CCEL’s FA Score: 2 green, 3 red.
  • NHC’s FA Score: 2 green, 3 red.
According to our system of comparison, CCEL is a better buy in the long-term than NHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCEL’s TA Score shows that 6 TA indicator(s) are bullish while NHC’s TA Score has 5 bullish TA indicator(s).

  • CCEL’s TA Score: 6 bullish, 4 bearish.
  • NHC’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CCEL is a better buy in the short-term than NHC.

Price Growth

CCEL (@Hospital/Nursing Management) experienced а -4.93% price change this week, while NHC (@Hospital/Nursing Management) price change was -1.34% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -10.44%. For the same industry, the average monthly price growth was -7.09%, and the average quarterly price growth was +3.25%.

Reported Earning Dates

CCEL is expected to report earnings on Feb 26, 2027.

Industries' Descriptions

@Hospital/Nursing Management (-10.44% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

CCEL and

Correlation & Price change

A.I.dvisor tells us that CCEL and NHC have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CCEL and NHC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCEL
1D Price
Change %
CCEL100%
-9.94%
NHC - CCEL
20%
Poorly correlated
-2.03%
ADUS - CCEL
20%
Poorly correlated
-0.58%
BKD - CCEL
20%
Poorly correlated
-2.39%
OPCH - CCEL
15%
Poorly correlated
+0.25%
CMPS - CCEL
13%
Poorly correlated
+1.75%
More

NHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NHC has been loosely correlated with HCSG. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if NHC jumps, then HCSG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NHC
1D Price
Change %
NHC100%
-0.69%
HCSG - NHC
46%
Loosely correlated
-0.68%
MD - NHC
37%
Loosely correlated
-2.38%
UHS - NHC
36%
Loosely correlated
-2.94%
PNTG - NHC
35%
Loosely correlated
-1.43%
ADUS - NHC
35%
Loosely correlated
-2.45%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CCOR27.45-0.22
-0.78%
Core Alternative Capital
GEM44.69-0.41
-0.91%
Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM)
SHE147.67-2.14
-1.43%
State Street SPDR MSCI USA Gender Diversity ETF (SHE)
RSSX22.17-0.43
-1.89%
Return Stacked U.S. Stocks & Gold/Bitcoin ETF (RSSX)
PLUL1.60-0.10
-5.95%
Leverage Shares 2X Long PLUG Daily ETF (PLUL)